» Articles » PMID: 30604395

5-aminolevulinic Acid Induced Protoporphyrin IX (ALA-PpIX) Fluorescence Guidance in Meningioma Surgery

Overview
Journal J Neurooncol
Publisher Springer
Date 2019 Jan 4
PMID 30604395
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: 5-aminolevulinic acid induced protoporphyrin IX (5-ALA-PpIX) fluorescence guidance has emerged as a valuable surgical adjunct for resection of intracranial tumors.

Methods: Here we present a focused review on 5-ALA-PpIX fluorescence guidance for meningiomas.

Results: We discuss the clinical studies and specific applications to date as well as the two main intraoperative fluorescence technologies applied to meningiomas.

Conclusions: The use of 5-ALA-PpIX in meningiomas holds promising potential so neurosurgeons can improve surgical outcomes for patients with meningiomas as well as be pioneers in developing improved fluorescence imaging technologies.

Citing Articles

Fluorescence-Guided Surgery Using 5-Aminolevulinic Acid/Protoporphyrin IX in Brain Metastases.

Price A, Bernstock J, Truong N, Wu K, Lee J, Tucker I Neurosurg Pract. 2025; 5(4):e00121.

PMID: 39959547 PMC: 11809973. DOI: 10.1227/neuprac.0000000000000121.


Whole-body fluorescence cryotomography identifies a fast-acting, high-contrast, durable contrast agent for fluorescence-guided surgery.

Scorzo A, Byrd B, Kwon C, Strawbridge R, Samkoe K, Hoopes P Theranostics. 2024; 14(17):6426-6445.

PMID: 39479457 PMC: 11519800. DOI: 10.7150/thno.100802.


Towards machine learning-based quantitative hyperspectral image guidance for brain tumor resection.

Black D, Byrne D, Walke A, Liu S, Ieva A, Kaneko S Commun Med (Lond). 2024; 4(1):131.

PMID: 38965358 PMC: 11224305. DOI: 10.1038/s43856-024-00562-3.


Topographic Patterns of Intracranial Meningioma Recurrences-Systematic Review with Clinical Implication.

Corvino S, Altieri R, La Rocca G, Piazza A, Corazzelli G, Palmiero C Cancers (Basel). 2024; 16(12).

PMID: 38927972 PMC: 11201517. DOI: 10.3390/cancers16122267.


Pharmaceutical equivalent 5-aminolevulinic acid fluorescence guided resection of central nervous system tumors: feasibility, safeness and cost-benefit considerations.

da Silva Jr E, Ramina R, Filho J, Jung G, Bornancin G, Neto M J Neurooncol. 2024; 168(3):555-562.

PMID: 38709355 DOI: 10.1007/s11060-024-04698-z.


References
1.
Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen H . Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000; 93(6):1003-13. DOI: 10.3171/jns.2000.93.6.1003. View

2.
Simpson D . The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957; 20(1):22-39. PMC: 497230. DOI: 10.1136/jnnp.20.1.22. View

3.
Stummer W, Reulen H, Novotny A, Stepp H, Tonn J . Fluorescence-guided resections of malignant gliomas--an overview. Acta Neurochir Suppl. 2003; 88:9-12. DOI: 10.1007/978-3-7091-6090-9_3. View

4.
Stummer W, Pichlmeier U, Meinel T, Wiestler O, Zanella F, Reulen H . Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006; 7(5):392-401. DOI: 10.1016/S1470-2045(06)70665-9. View

5.
Bradley R, Thorniley M . A review of attenuation correction techniques for tissue fluorescence. J R Soc Interface. 2006; 3(6):1-13. PMC: 1618480. DOI: 10.1098/rsif.2005.0066. View